Effect of orlistat in overweight or obese patients with treated but inadequately controlled diastolic hypertension

被引:0
作者
Bakris, G
Calhoun, D
Egan, B
Hellmann, C
Kingma, I
机构
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[2] Univ Alabama, Birmingham, AL USA
[3] Med Univ S Carolina, Charleston, SC 29425 USA
[4] Roche Labs Inc, Nutley, NJ USA
来源
OBESITY RESEARCH | 2001年 / 9卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:188S / 188S
页数:1
相关论文
共 50 条
  • [21] Positive effect of Orlistat on controlling blood glucose levels in overweight and obese patients with Type 2 diabetes
    Valensi, P
    Eschwège, E
    Drouin, P
    Gin, H
    Joubert, J
    Guy-Grand, B
    DIABETOLOGIA, 2002, 45 : A220 - A220
  • [23] Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus
    Maetzel, A
    Rouf, J
    Covington, M
    Wolf, A
    PHARMACOECONOMICS, 2003, 21 (07) : 501 - 512
  • [24] Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus
    Andreas Maetzel
    Jörg Ruof
    Melva Covington
    Anne Wolf
    PharmacoEconomics, 2003, 21 : 501 - 512
  • [25] THE EFFECT OF MODIFIED SHAM FEEDING WITH ORLISTAT IN OVERWEIGHT AND OBESE SUBJECTS: A PILOT STUDY
    Dubin, R. L.
    Fusiler, K.
    Greenway, F.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 397 - 397
  • [26] Effect of orlistat in obese patients with binge eating disorder
    Golay, A
    Laurent-Jaccard, A
    Habicht, F
    Gachoud, JP
    Chabloz, M
    Kammer, A
    Schutz, Y
    OBESITY RESEARCH, 2005, 13 (10): : 1701 - 1708
  • [27] Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study
    Filippatos, TD
    Kiortsis, DN
    Liberopoulos, EN
    Georgoula, M
    Mikhailidis, DP
    Elisaf, MS
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (12) : 1997 - 2006
  • [28] Effect of orlistat on the need for concomitant anti-diabetic medication in overweight and obese patients with type 2 diabetes
    Miles, JM
    Halpern, A
    DIABETES, 2002, 51 : A475 - A475
  • [30] Effect of orlistat on the systemic inflammation parameters in obese patients
    Formiguera, Xavier
    Sierra, Angel
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S171 - S171